S2 E8: Medical Cannabis: Wider NHS Access & Clinical Trials- Melissa Sturgess, CEO of Ananda

Ananda is a publicly listed pharmaceutical company focused on the development of cannabinoid-based drugs for the treatment of a range of complex, chronic inflammatory pain conditions.  Ananda’s team of seasoned, successful and driven entrepreneurs aim to deliver robust clinical trials in order to make their medicines available on the NHS.  In this episode, CEO Melissa Sturgess unpacks Ananda’s plans, ethos and what makes them a truly ground-breaking medical cannabis company.  Find out more about Ananda at https://anandadevelopments.com/  Discussing a range of topics including: -How medicines reach the NHS -What conditions are Ananda launching trials for? -Investing in clinical trials – Government funding or private equity? -Campaigning for NHS access – What can we do? -How to build a pharmaceutical cannabis company   -----------------------------------------------------------------------------------------------------Grow Conversations is your window into the world of medical cannabis.Brought to you by Grow Group UK - Unlocking the Medical Potential of CannabisGrow Group's Links: https://growgroup.komi.io/Follow Alex: https://linktr.ee/alexfrasercannaStay tuned for the next episode coming soon!